Badges (1)

About

Member has chosen to not make this information public.

Groups (1)

Pages

Member not yet following any Pages.

Posts (2)

Jul 8, 2018 · Concern over MRI dye in Breast Cancer

Thanks for your response. Although we are in different situations, it sounds as if we are facing similar decisions re: MRI. My long-term hope is that if gadolinium is problematic, another contrast agent will be found that is not. Meantime, I'm uneasy about how to monitor for a recurrence of the lobular cancer, or a new lobular tumor in the other breast. I may start a thread here to see what others with invasive lobular carcinoma have done.

Jul 8, 2018 · Concern over MRI dye in Breast Cancer

I am also concerned about MRI with contrast. I had a pre-surgery MRI a year ago, before my lumpectomy. I am now discussing with my oncologist whether to follow up my 3-D mammogram, which was clear, with MRI, since I had both invasive ductal carcinoma and invasive lobular carcinoma in the same breast. Lobular carcinoma does not show up well on mammography or ultrasound. I read this information from Mayo. https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-finds-direct-evidence-of-gadolinium-deposition-in-brain-tissues-following-contrast-enhanced-mri-exams/
Is it possible to have an MRI without the use of gadolinium for breast cancer followup? Is there an alternative type of contrast? I'm having difficulty finding sufficient information on this to enable me to make an informed decision. I understand that some types of gadolinium contrast are no longer being used in Europe and that the FDA has updated a warning about gadolinium use. https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm589604.htm